Fenofibrate and Valchlor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fenofibrate (fenofibrate) and Valchlor (mechlorethamine hydrochloride). Common drug interactions include application site pruritus among females and erythema among males.

The phase IV clinical study analyzes what interactions people have when they take Fenofibrate and Valchlor. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,456 Fenofibrate users. Check the latest studies of Fenofibrate.

What is Valchlor?

Valchlor has active ingredients of mechlorethamine hydrochloride. eHealthMe is studying from 2,539 Valchlor users. Check the latest studies of Valchlor.

On Apr, 18, 2026

27 people who take Fenofibrate and Valchlor together, and have interactions are studied.

Fenofibrate and Valchlor drug interactions.

What are the common drug interactions of Fenofibrate and Valchlor, by gender? *:

female:

Application site pruritus (application site severe itching of the skin)
Skin irritation
Skin lesion
Application site rash
Bacterial infection
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Dry skin
Erythema (redness of the skin)
Hypertension (high blood pressure)
Pneumonia

male:

Erythema (redness of the skin)
Skin burning sensation
Mycosis fungoides (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin)
Staphylococcal bacteraemia (a bacterial infection of blood)
Application site pruritus (application site severe itching of the skin)
Application site rash
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Death
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
Disease progression

What are the common drug interactions of Fenofibrate and Valchlor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Skin irritation
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Burning sensation
Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
Generalised erythema (redness of the skin all over the body)
Papule
Telangiectasia (small dilated blood vessels near the surface of the skin)

60+:

Erythema (redness of the skin)
Application site pruritus (application site severe itching of the skin)
Disease progression
Skin burning sensation
Skin discolouration (change of skin colour)
Application site erythema (redness of the skin at application site)
Application site pain
Drug ineffective
Staphylococcal bacteraemia (a bacterial infection of blood)
Death

What are the existing conditions these people have? *

Mycosis Fungoides (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin): 17 people, 62.96%
T-Cell Lymphoma (a blood cell cancer): 2 people, 7.41%
Skin Cancer: 2 people, 7.41%
Hypertriglyceridaemia (excess of triglycerides in the blood): 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Fenofibrate and Valchlor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously